S'abonner

Reconstruction after wide excision of primary cutaneous melanomas: part II—the extremities - 11/08/11

Doi : 10.1016/S1470-2045(09)70121-4 
Marc D Moncrieff, FRCS Plast c, , John F Thompson, ProfFRACS a, b, Michael J Quinn, FRACS a, b, Jonathan R Stretch, FRACS a, b
a Sydney Melanoma Unit and Melanoma Institute of Australia, North Sydney, Australia 
b Discipline of Surgery, The University of Sydney, Sydney, Australia 
c Department of Plastic and Reconstructive Surgery Norfolk and Norwich University Hospital, Norwich, UK 

*Correspondence to: Mr Marc D Moncrieff, Department of Plastic and Reconstructive Surgery, Norfolk and Norwich University Hospital Foundation NHS Trust, Colney Lane, Norwich, Norfolk NR4 7UY, UK

Summary

The core principle in the management of primary cutaneous melanoma is wide surgical excision, but occasionally a balance is needed between adequately resecting a potentially curable lesion and minimising the functional deficit in manual dexterity or ambulation for the patient. A secondary but nonetheless increasingly important consideration in this location is the potential cosmetic deformity caused by wide excision of the melanoma. Thus, the reconstructive surgeon forms an integral part of a multidisciplinary team managing patients with melanoma by providing knowledge of a wide range of reconstructive techniques, including the advantages and limitations, and a comprehensive understanding of the local and regional anatomy. The primary aim of this article is to review the current literature and available evidence on reconstruction after wide excision of primary cutaneous melanoma of the extremities.

Le texte complet de cet article est disponible en PDF.

Plan


© 2009  Elsevier Ltd. Tous droits réservés.© 2009  Springer. Publié par Elsevier Masson SAS. Tous droits réservés.© 2009  Springer. Publié par Elsevier Masson SAS. Tous droits réservés.
Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 10 - N° 8

P. 810-815 - août 2009 Retour au numéro
Article précédent Article précédent
  • Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease
  • Darren R Carpizo, Michael D’Angelica
| Article suivant Article suivant
  • Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
  • Kenneth R Carson, Daniele Focosi, Eugene O Major, Mario Petrini, Elizabeth A Richey, Dennis P West, Charles L Bennett

Déjà abonné à cette revue ?